Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Pacibekitug, an antibody targeting IL6.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Ozureprubart, an antibody targeting IgE.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Ocankitug, an antibody targeting TSLP.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Obrixtamig, an antibody targeting DLL3 × CD3E.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Negalstobart, an antibody targeting LAG-3.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Navenibart, an antibody targeting Plasma kallikrein.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Misitatug, an antibody targeting MSLN.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Lumrotatug, an antibody targeting ADPRC1.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Libevitug, an antibody targeting Hepatitis B Virus Surface Antigen.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Invikafusp, an antibody targeting TRBV6&TRBV10.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Indenebart, an antibody targeting alpha-synuclein.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Gruticibart, an antibody targeting Factor XI.